HomeMarket NewsVigil Neuroscience research for Alzheimer's drug to proceed with FDA restrictions

Vigil Neuroscience research for Alzheimer's drug to proceed with FDA restrictions

Actionable Trade Ideas

always free

FDA written on wooden cube with keyboard , calculator, chart,glasses.Business concept

Iryna Drozd

Vigil Neuroscience (NASDAQ:VIGL) mentioned the FDA is permitting a Part 1 scientific trial for its Alzheimer’s drug candidate VG-3927 to proceed with a partial scientific maintain associated to the utmost drug publicity restrict.

Vigil mentioned it expects to start dosing

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.